| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/27/2003 | WO2002070709A3 Molecules for disease detection and treatment |
| 02/27/2003 | WO2002068620A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/27/2003 | WO2002067858A3 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms |
| 02/27/2003 | WO2002064736A3 Protein-protein interactions |
| 02/27/2003 | WO2002064172A3 Fhit gene therapy prevents tumor development in fhit-deficient mice |
| 02/27/2003 | WO2002062203A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/27/2003 | WO2002061040A3 Gene delivery formulations and methods for treatment of ischemic conditions |
| 02/27/2003 | WO2002060951A3 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 02/27/2003 | WO2002060411A3 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 02/27/2003 | WO2002058717A3 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 02/27/2003 | WO2002055714A3 Human protease and polynucleotides encoding the same |
| 02/27/2003 | WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002055024A3 Therapeutic modulation of the tumor inflammatory response |
| 02/27/2003 | WO2002055022A3 Active metabolite of antifungal compound |
| 02/27/2003 | WO2002053755A3 Regulation of human otu-like cysteine protease |
| 02/27/2003 | WO2002053716A3 Regulation of human ornithine decarboxylase |
| 02/27/2003 | WO2002049611A3 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 02/27/2003 | WO2002049577A3 Analogues of thiocoraline and be-22179 |
| 02/27/2003 | WO2002048329A3 Membrane derived caspase-3, compositions comprising the same and methods of use therefor |
| 02/27/2003 | WO2002048328A3 Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| 02/27/2003 | WO2002048184A3 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 02/27/2003 | WO2002043695A3 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002041911A3 Use of fgf-19 for inhibiting angiogenesis |
| 02/27/2003 | WO2002040637A3 Antisense modulation of pi3k p85 expression |
| 02/27/2003 | WO2002038105A3 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 02/27/2003 | WO2002036142A3 Compositions for inhibiting grb7 |
| 02/27/2003 | WO2002036136A3 Compositions and methods for prolonging survival of chilled platelets |
| 02/27/2003 | WO2002031161A3 Regulation of human phospholipase-like enzyme |
| 02/27/2003 | WO2002031156A3 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/27/2003 | WO2002029047A3 Regulation of human gpcr-like protein |
| 02/27/2003 | WO2002028425A3 Methods for treating muscle injuries |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | WO2002020768A3 Caveolin peptides and their use as therapeutics |
| 02/27/2003 | WO2002020767A3 G-csf analog compositions and methods |
| 02/27/2003 | WO2002018555A3 Human kinase proteins and polynucleotides encoding the same |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/27/2003 | WO2002009644A3 Angiogenic and osteogenic proteins for use in enhancing bone density and formation |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002006308A3 Methods for promoting dendritic cell proliferation or differentiation |
| 02/27/2003 | WO2002004605A3 Stimulation of cellular regeneration and differentiation in the inner ear |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098481A3 Renal regulatory elements and methods of use thereof |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001097861A3 Vitronectin receptor antagonist pharmaceuticals |
| 02/27/2003 | WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 02/27/2003 | WO2001093889A3 Vip-related peptides for the treatment of skin disorders |
| 02/27/2003 | WO2001092892A3 Methods to identify compounds that modulate rage |
| 02/27/2003 | WO2001090160A3 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| 02/27/2003 | WO2001085924A3 MODULATION OF η-SECRETASE ACTIVITY |
| 02/27/2003 | WO2001075164A3 Rna sequence-specific mediators of rna interference |
| 02/27/2003 | US20030041344 Receptor kinase, BIN1 |
| 02/27/2003 | US20030041341 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in DNA encoding 4E-BP1 |
| 02/27/2003 | US20030041328 Method and system for providing a customized media list |
| 02/27/2003 | US20030040617 For detecting, prophylaxis and therapy of disorders of the colon and/or rectum, including, but not limited to, the presence of colorectal cancer and colorectal cancer metastases |
| 02/27/2003 | US20030040611 Nucleotide sequences coding polypeptide for use in the treatment of nervous system and bone disorders |
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040603 Purified mammalian CTLA-8 antigens and related reagents |
| 02/27/2003 | US20030040600 Thrombin generation inhibitors |
| 02/27/2003 | US20030040515 Exposing the multimeric von Willebrand factor (vWF) to thrombospondin-1 (TSP-1) or a functional fragment thereof for disrupting multimeric vWF |
| 02/27/2003 | US20030040509 Methods and compositions for treating diseases associated with excesses in ACE |
| 02/27/2003 | US20030040496 Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehicles |
| 02/27/2003 | US20030040487 Polymer complexes of glucuronoglucanes |
| 02/27/2003 | US20030040486 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time |
| 02/27/2003 | US20030040485 For use in theray |
| 02/27/2003 | US20030040484 Administering a therapeutically-effective amount of an angiotensin converting enzyme inhibitor and administering an aldosterone antagonist to reduce the death rate or the number of non-fatal hospitalizations |
| 02/27/2003 | US20030040483 Compounds with growth hormone releasing properties |
| 02/27/2003 | US20030040482 For therapy of precocious puberty, prostate cancer, ovarian cancer, benign prostatic hypertrophy, endometriosis, uterine fibroids, breast cancer, premenstrual syndrome, polycystic ovary syndrome, disease caused by excesses of gonadal hormones |
| 02/27/2003 | US20030040481 Contacting a tissue factor(TF)-expressing cell with a motility modifying-effective amount of a compound selected from the group consisting of Factor VIIa; a Factor VIIa agonist; and a Factor VIIa antagonist for modifying cell motility |
| 02/27/2003 | US20030040480 Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
| 02/27/2003 | US20030040479 Rotational intrathecal analgesia method and device |
| 02/27/2003 | US20030040478 Chemotherapy treatment |
| 02/27/2003 | US20030040477 Methods and compositions for modulating t cell activation and uses thereof |
| 02/27/2003 | US20030040476 EAG gene |
| 02/27/2003 | US20030040475 Agents for improving lipid metabolism and reducing high blood pressure |
| 02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040472 Novel peptide conjugates |
| 02/27/2003 | US20030040471 For stimulating keratinocyte growth and motility; for inhibiting the growth of cancer cells; for modulating angiogenesis for modulating skin inflammation; for stimulating the growth of epithelial cells |
| 02/27/2003 | US20030040470 For therapy of hypercholesterolemia, viral infection |
| 02/27/2003 | US20030040469 Using GLP-1(peptide) agonist for the manufacture of a medicament for lowering total serum lipids |
| 02/27/2003 | US20030040468 For therapy of respiratory distress of the lungs |
| 02/27/2003 | US20030040467 Administering an effective amount of an OB protein, analog or derivative for increasing lean tissue mass |
| 02/27/2003 | US20030040465 Neuregulins as modulators of cellular communication |
| 02/27/2003 | US20030040462 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance |
| 02/27/2003 | US20030040461 Providing a cell expressing Bruton's Tyrosine Kinase; contacting cell expressing Bruton's Tyrosine Kinase with a test compound; determining whether test compound modulates the activity of Bruton's Tyrosine Kinase |
| 02/27/2003 | US20030040112 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 02/27/2003 | US20030040111 Differentiated cells suitable for human therapy |
| 02/27/2003 | US20030040097 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of liver, immunological, kidney, cancer and cell proliferative disorders |
| 02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
| 02/27/2003 | US20030040095 Generation of preferential protein for use in the trement of thrombosis and heart defscts; obtain cells, transform with vector containing preferential protein, recover transformed cells, propagate, recover protein |
| 02/27/2003 | US20030040094 ATP diphosphohydrolase for use in the treatment of pancreatic and heart disorders |
| 02/27/2003 | US20030040088 Protein for use in the treatment of immune, blood, gastrointestinal, and cancer disorders |
| 02/27/2003 | US20030040082 Mutant pro-neurotrophin with improved activity |
| 02/27/2003 | US20030040081 Galectin 9 and 10SV polynucleotides |
| 02/27/2003 | US20030040054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040053 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders and tumors |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030040050 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |